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Lysine-specific demethylase 1 promotes
brown adipose tissue thermogenesis via
repressing glucocorticoid activation
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and Bruce M. Spiegelman1,2
1Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, USA; 2Department of Cell Biology, Harvard Medical School,
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Brown adipocytes display phenotypic plasticity, as they can switch between the active states of fatty acid oxidation
and energy dissipation versus a more dormant state. Cold exposure or β-adrenergic stimulation favors the active
thermogenic state, whereas sympathetic denervation or glucocorticoid administration promotes more lipid accu-
mulation. Our understanding of themolecularmechanisms underlying these switches is incomplete. Herewe found
that LSD1 (lysine-specific demethylase 1), a histone demethylase, regulates brown adipocyte metabolism in two
ways. On the one hand, LSD1 associates with PRDM16 to repress expression of white fat-selective genes. On the
other hand, LSD1 represses HSD11B1 (hydroxysteroid 11-β-dehydrogenase isozyme 1), a key glucocorticoid-acti-
vating enzyme, independently from PRDM16. Adipose-specific ablation of LSD1 impaired mitochondrial fatty acid
oxidation capacity of the brown adipose tissue, reduced whole-body energy expenditure, and increased fat deposi-
tion, which can be significantly alleviated by simultaneously deleting HSD11B1. These findings establish a novel
regulatory pathway connecting histonemodification and hormone activationwithmitochondrial oxidative capacity
and whole-body energy homeostasis.
[Keywords: LSD1; PRDM16; HSD11B1; brown adipose tissue; thermogenesis; mitochondria]
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The increased prevalence of obesity poses a significant
challenge to human health, as obese individuals are pre-
disposed to multiple pathological conditions, such as car-
diovascular diseases, type 2 diabetes, hypertension, and
certain types of cancer (Després and Lemieux 2006; Gaal
et al. 2006; Kahn et al. 2006; Basen-Engquist and Chang
2011). Obesity or excessive expansion of the adipose tis-
sue is a consequence of chronic energy imbalance be-
tween energy intake and dissipation. Two major classes
of adipose tissues exist in mammals—white and brown
—with distinct anatomical locations, developmental ori-
gins, and physiological functions. White adipose tissue
(WAT) has low mitochondrial content and is specialized
for storing excess energy in the form of triacylglycerides.
In contrast, brown adipose tissue (BAT) features very
high mitochondrial content and is capable of performing
high rates of fatty acid oxidation (FAO) followed by dissi-
pation of the harnessed energy in the form of heat, a pro-
cess known as nonshivering thermogenesis (Cannon and
Nedergaard 2004). Promoting FAO and thermogenesis
represents a potential therapy to increase energy expendi-
ture and combat obesity.
Both the BAT and WAT display phenotypic plasticity,
as each type can take on the counterpart’s morphological
and functional features in response to temperature or hor-
mone stimuli. Under conditions such as cold exposure or
β-adrenergic stimulation, cells similar to brown adipo-
cytes emerge in the WAT depots (Loncar 1991; Ghorbani
and Himms-Hagen 1997), an inducible population also
known as the “beige” adipocytes. Beige cells are a distinct
cell type from classical brown fat cells and have different
developmental origins (Wu et al. 2012; Long et al. 2014). It
is important to note that sympathetic denervation or glu-
cocorticoid (GC) administration represses the FAO/ther-
mogenic capacity of the BAT and causes it to enter a
dormant state. Such effects are fully reversible upon β-ad-
renergic agonist supplementation or GC retrieval (Dulloo
andMiller 1984;Minokoshi et al. 1986; Strack et al. 1995).
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However, the molecular basis of the phenotypic plasticity
of adipocytes remains to be fully explored.
Our laboratory previously identified a BAT-enriched
transcriptional coregulator, PRDM16, that drives the ex-
pression of mitochondrial and thermogenic genes in
brown and beige adipocytes (Seale et al. 2007). Transgenic
expression of PRDM16 in the adipose tissues results in in-
creased levels of mitochondrial and thermogenic genes in
the WAT, reflecting expansion of the beige population
(Seale et al. 2011). Conversely, ablation of PRDM16mark-
edly inhibits beige adipocyte development and function
(Cohen et al. 2014). Classical brown fat required deletion
of both PRDM16 and PRDM3 to ablate thermogenic
gene expression completely, but BAT from mice deleted
in only PRDM16 show marked age-related reduction
in expression of a wide range of mitochondrial and ther-
mogenic genes (Harms et al. 2014). These findings have
clearly established a role of PRDM16 in driving the ther-
mogenic program in both brown and beige adipocytes.
Whereas PRDM16’s function in the transcriptional ac-
tivation of the thermogenic gene program has been well
established, two lines of evidence suggest that it could
also act as a transcriptional corepressor. First, knocking
down PRDM16 from the precursors isolated from the
BAT results in differentiation of these cells into myocytes
(Seale et al. 2008). Interestingly, lineage tracing experi-
ments revealed that both the BAT and skeletal muscle
are derived from a common population of myf5-positive
progenitors (Seale et al. 2008). These observations there-
fore suggest that PRDM16 may repress the myogenic
program during the process of brown adipocyte differenti-
ation. Second, ablating PRDM16 from the BAT results in
increased expression ofWAT-selective genes (Harms et al.
2014). Importantly, the up-regulation of WAT-selective
genes is evident in the BAT of mice lacking PRDM16 as
young as 6 wk, whereas significant down-regulation of
thermogenic genes does not occur until the mice reach
3–6mo of age (Harms et al. 2014). These observations sug-
gest that the increased expression of WAT-selective genes
is probably not secondary to the decreased expression of
the BAT-selective thermogenic genes; instead, it may re-
flect a primary consequence of loss of transcriptional re-
pression by PRDM16. Consistent with this, PRDM16
was found to physically associate with the transcriptional
corepressors CTBP1 and CTBP2, and its ability to repress
some WAT-selective genes in adipocytes is dependent on
these corepressors (Kajimura et al. 2008). Given the evi-
dence that PRDM16 represses both the myogenic and
WAT-selective genes in brown adipocytes, the molecular
mechanism underlying PRDM16-mediated transcription-
al repression becomes an important question to address.
Here, we show that PRDM16 interacts with lysine-spe-
cific demethylase 1 (LSD1, also known as KDM1A), a re-
pressive histone-modifying enzyme that demethylates
monomethyl-H3K4 or dimethyl-H3K4, both of which
are histone markers closely associated with promoters
and enhancers of actively transcribed genes. LSD1 defi-
ciency impairs the FAO/thermogenic capacity of the
BAT and reduces whole-body energy expenditure;
this could be substantially alleviated by simultaneously
deleting HSD11B1 (hydroxysteroid 11-β-dehydrogenase
isozyme 1), a gene controlling GC activation that is in-
duced by LSD1 deficiency. Taken together, these results
establish that LSD1 plays a critical role in BAT via repress-
ing HSD11B1, thus preventing local GC excess.
Results
LSD1 associates with PRDM16 and represses
WAT-selective genes in brown adipocytes
To understand the molecular basis of PRDM16-mediated
repression of WAT-selective genes in BAT, we immune-
purified the endogenous PRDM16 complex from nuclear
extracts of primary brown adipocytes with antibody
highly specific to PRDM16 (Supplemental Fig. S1). Bound
proteins were eluted with glycine and subjected to quanti-
tativemass spectrometrywith isobaric tagging. A series of
known members of the CTBP corepressor complex were
found to be highly enriched in the anti-PRDM16 pull-
down relative to the IgG control, including CTBP1,
CTBP2, RCOR1, RCOR3, ZNF516, HDAC1, HDAC2,
and KDM1A (Table 1; Shi et al. 2003). The same set of pro-
teins was identified when we purified Flag-tagged
PRDM16 expressed in primary brown adipocytes via ade-
noviral infection (Table 2). A complete list of the peptides
identified is in Supplemental Table S1. We confirmed the
presence of KDM1A and CTBP1 in the endogenous or
Flag-tagged PRDM16 complex by Western blot (Fig. 1A).
KDM1A, commonly known as LSD1, demethylates
monomethylated or dimethylated histone H3 Lys4
(H3K4me1 or H3K4me2), which are histone markers
closely associated with active transcription (Shi et al.
2004). H3K4me1 is particularly enriched at active enhanc-
ers, whereas H3K4me2 is more associated with promoter
regions of active or poised genes. By removing these mod-
ifications, LSD1 acts as a corepressor on its target genes.
We therefore investigated whether LSD1 cooperates
with PRDM16 to repress WAT-selective genes in the
BAT. We treated primary brown adipocytes with S2101,
a mechanism-based small molecule inhibitor of LSD1,
and observed dose-dependent increases in a series of
WAT-selective genes. For example, retn and agt mRNA
levels increase by twofold at the highest dose (Fig. 1B).
Table 1. Endogenous PRDM16 is associated with components
of the CTBP corepressor complex as identified by mass
spectrometry
Gene symbol Peptide IgG PRDM16 PRDM16/IgG
Prdm16 60 4138.9 146060.0 35.29
Ctbp1 16 1992.7 47328.3 23.75
Znf516 38 5164.6 60967.2 11.80
Kdm1a 19 3273.8 30511.2 9.32
Rcor1 8 963.0 8499.7 8.83
Ctbp2 5 1140.4 6262.3 5.49
Hdac1 10 2382.2 8779.98 3.69
Hdac2 4 1032.87 3526.17 3.41
Rcor3 4 1479.04 4535.16 3.07
LSD1 represses HSD11B1 to promote BAT activity
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These genes are also up-regulated in the PRDM16-defi-
cient BAT (Matthew et al. 2014). Pharmacological inhibi-
tion of LSD1 had no effect on the expression of pan-
adipocyte genes, including fabp4, adipoq, and pparg (Fig.
1B). Modest decreases in the expression were also ob-
served for certain BAT-selective genes, such as ucp1 and
cidea (Fig. 1B).
Ablation of LSD1 results in increases in expression
of WAT-selective genes in the BAT
We next sought to investigate this phenomenon with a
loss-of-function genetic model of LSD1. For this purpose,
we generated mice lacking LSD1 specifically in the
adipose tissue by crossing an adiponectin-Cre line to a
LSD1 floxed line (Kerenyi et al. 2013). The resulting
lsd1loxP/loxP, cre+ mice (referred to here as adipose-specific
LSD1knockout [AdLKO]) display a large reduction in both
the protein and themRNA levels of LSD1 in the interscap-
ular BAT, inguinal subcutaneous WAT, and epididymal
WAT; such reductions were not observed in the liver (Fig.
2A). We isolated the stromal vascular fractions from the
BAT of the control and AdLKO mice and differentiated
them into brown adipocytes in vitro. We observed in-
creased expression of the same set ofWAT-selective genes
in the LSD1-deficient brown adipocytes as was seen with
the pharmacological LSD1 inhibition. For example, retn
expression increased by 1.8-fold, and agt increased by
1.5-fold (Fig. 2B). Again, we observed no difference in the
expression of pan-adipocyte genes such as fabp4, adipoq,
and pparg and only modest decreases in some but not
all BAT-selective genes in the LSD1-deficient brown
Table 2. Flag-tagged PRDM16 is associated with components
of the CTBP corepressor complex as identified by mass
spectrometry
Gene Symbol Peptides −Ad +Ad +Ad/−Ad
Prdm16 103 927.6 42083.6 45.37
Znf516 14 139.6 5561.4 39.83
Ctbp2 6 57.8 1282.8 22.21
Ctbp1 6 95.8 1752.1 18.28
Rcor1 6 142.1 1099.5 7.74
Rcor3 3 111.5 806.9 7.24
Kdm1a 5 388.4 2673.9 6.88
Hdac2 2 209.2 549.5 2.63
Hdac1 3 223.4 339.0 1.52
(Ad) Adenovirus.
Figure 1. LSD1 associates with PRDM16
and represses white selective genes in
brown adipocytes. (A) Western blot for
PRDM16, LSD1, and CTBP1 protein levels
in purified endogenous or Flag-tagged
PRDM16 complexes. (B) mRNA levels of
pan-adipocyte and brown- and white-selec-
tive genes in brown adipocytes treated with
S2101, a small molecule inhibitor of LSD1.
Mean ± SEM. n = 3. (∗) P < 0.05; (∗∗) P < 0.01.
Zeng et al.
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adipocytes relative to the control (Fig. 2B). This is in strik-
ing contrast to PRDM16-deficient brown adipocytes in
that the latter display strong reduction in the expression
of BAT-selective genes (Harms et al. 2014). These observa-
tions suggest that the ability of PRDM16 to repress WAT-
selective genes via LSD1 is functionally separable from its
ability to activate BAT-selective genes. Importantly, ex-
pressing the wild-type LSD1 but not a catalytically inac-
tive mutant of LSD1 (K661A) in the LSD1-deficient
brown adipocytes restored repression of the WAT-selec-
tive genes (Fig. 2C), indicating that the enzymatic activity
ofLSD1 is required for repressing theWAT-selectivegenes.
We next performed a global comparison of the expres-
sion profile of the PRDM16-deficient and the LSD1-
Figure 2. Ablation of LSD1 results in up-regulation ofwhite-selective genes in brown adipocytes. (A)mRNAand protein levels of LSD1 in
the adipose tissue of control andAdLKOmice.Mean ± SEM. n = 5. (∗∗∗) P < 0.001. (B) mRNA levels of pan-adipocyte and brown- andwhite-
selective genes in control and LSD1-deficient brown adipocytes differentiated in vitro. Mean ± SEM. n = 6. (∗) P < 0.05; (∗∗) P < 0.01. (C )
mRNA levels of white-selective genes in LSD1-deficient brown adipocytes expressing wild-type LSD1or a catalytically inactive mutant
of LSD1 (K661A).Mean ± SEM.n = 6. (∗)P < 0.05; (∗∗) P < 0.01. (D) Heatmap comparison of genes that are significantly changed in the LSD1-
deficient and PRDM16-deficient BAT relative to the control. (E) mRNA levels of white-selective genes in the control and LSD1-deficient
BAT. (AdLHKO) Heterozygous LSD1 knockout. Mean ± SEM. n = 5. (∗∗) P < 0.01; (∗∗∗) P < 0.001. (F ) mRNA levels of pan-adipocyte and
brown-selective genes in the control and LSD1-deficient BAT. (AdLHKO) Heterozygous LSD1 knockout. Mean ± SEM. n = 5.
LSD1 represses HSD11B1 to promote BAT activity
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deficient BAT. At a threshold of 1.5-fold change, RNA se-
quencing (RNA-seq) analysis identified 1141 significantly
up-regulated genes and 455 significantly down-regulated
genes in the AdLKO relative to the control. A previously
published microarray analysis of the PRDM16-deficient
BAT identified 1702 significantly up-regulated genes and
1834 significantly down-regulated genes (Harms et al.
2014). Comparison of the two data sets revealed an over-
lap of 269 up-regulated genes but only 52 down-regulated
genes (Fig. 2D). Assuming that the PRDM16 and LSD1
gene sets are completely independent, the P-value for
the down-regulated gene sets to have an overlap of 52 or
more is ∼0.24, whereas the P-value for the up-regulated
genes to have an overlap of 269 or more is <0.00001.
Hence, this analysis indicates that there exists a much
more significant overlap between the up-regulated genes
in the LSD1-deficient and PRDM16-deficient BAT than
those down-regulated by these manipulations in vivo.
Moreover, we observed a strongly preferred presence for
WAT-selective genes in the overlapping set of 269 genes
but not the remaining 872 genes up-regulated in the
LSD1-deficient BAT (Fig. 2D; Supplemental Fig. S2), sug-
gesting that the common set of genes being repressed by
PRDM16 and LSD1 is predominantly WAT-selective.
We confirmed by quantitative PCR (qPCR) that the in-
creased expression of WAT-selective genes occurs only
in the homozygous but not the heterozygous LSD1 knock-
out BAT, suggesting that this is a phenotype specific to
LSD1 ablation but not to the presence of the floxed allele
or the CRE recombinase (Fig. 2E). Unlike in vitro experi-
ments, we observed no reduction in the BAT-selective
genes ucp1 and cidea in the LSD1-deficient BAT (Fig.
2F). These results from global expression analyses are con-
sistent with the effects of pharmacological inhibition or
genetic ablation of LSD1 on gene expression in brown ad-
ipocytes differentiated in vitro and emphasize again that
the corepressor function of LSD1 and PRDM16 is strongly
correlated, whereas their abilities to activate gene tran-
scription are largely independent.
LSD1 and PRDM16 repression of WAT-selective genes
correlates with the demethylation of H3K4
We sought to determine whether the LSD1-mediated and
PRDM16-mediated repression of WAT-selective genes
reflected a direct action of these proteins; thus, we per-
formed chromatin immunoprecipitation (ChIP) sequenc-
ing (ChIP-seq) of LSD1 and PRDM16 to identity their
genomic binding sites. We identified 22,274 peaks in
LSD1 ChIP-seq and 22,537 peaks in PRDM16 ChIP-seq
(Fig. 3A). There are 9.7% of PRDM16 and 19.5% of
LSD1 peaks located in the promoter region of target genes,
both of which are significantly enriched relative to the ge-
nomic level (2.7%) (Fig. 3A). There is a significant overlap
of 11,843 between the two sets of peaks, marking sites of
co-occupancy by LSD1 and PRDM16. We observed highly
enriched motifs of the transcription factor CCAAT/en-
hancer-binding protein α (C/EBPa) and the early B-cell fac-
tor (EBF) present in both the PRDM16 and LSD1 peaks
(Fig. 3B). Indeed, we detected C/EBPa and EBF3 by mass
spectrometry in the purified endogenous PRDM16 com-
plex (Supplemental Table S2), suggesting that C/EBPa or
EBF3 may be responsible for recruiting the PRDM16/
LSD1 complex to certain genomic loci. In addition, we ob-
served themotif of transcription factor RE-1 silencing fac-
tor (REST) and SIX5 to be highly enriched in the LSD1 but
not the PRDM16 peaks (Fig. 3B), suggesting that, apart
from interacting with C/EBPa and EBF3, LSD1 may also
associate with additional transcription factors and target
to other genomic loci independently.
The genomic distribution of the PRDM16 and LSD1
peaks relative to their target genes of regulation was
then analyzed. Among the common set of 269 genes
that are up-regulated in both the PRDM16-deficient and
LSD1-deficient BAT, 51 (19%) genes have colocalized
PRDM16 and LSD1 peaks in the promoter-proximal re-
gion, suggesting that these genes may be direct targets of
repression by PRDM16 and LSD1. For example, we ob-
served colocalization of PRDM16 and LSD1 in the pro-
moter-proximal regions of WAT-selective genes such as
retn and agt (Fig. 3C). This is likely an underestimation
because the contribution from occupancy of distal en-
hancers by PRDM16 and LSD1 is not considered. Impor-
tantly, we observed significantly increased local levels of
H3K4me1 or H3K4me2 near the promoter-proximal re-
gions ofWAT-selective genes that are targets of repression
by PRDM16 and LSD1 in either PRDM16-deficient or
LSD1-deficient BAT, such as retn and agt (Fig. 3C), further
supporting the idea that repression of these genes is a di-
rect consequence of local demethylation mediated by
LSD1. Interestingly, loss of PRDM16 results in a much
more extensive increase in the local H3K4me1 and
H3K4me2 level near the agt gene than what is observed
with the LSD1-deficient BAT (Fig. 3C), which is consis-
tent with the fact that agt is up-regulated by nearly 20-
fold in the PRDM16-deficient BAT but only twofold in
the LSD1-deficient BAT. This suggests that additional
mechanisms not involving LSD1 may be used to regulate
histone methylation levels near PRDM16-binding sites.
AdLKOmice have increased fatmass and reduced energy
expenditure
We then characterized the metabolic phenotype of the
AdLKOmice. Strikingly, even on a chow diet, the AdLKO
mice have significantly increased body weights relative to
the control (lsd1loxP/loxP) (Fig. 4A). The weight divergence
is significant as early as 4wkof age (Fig. 4A).Magnetic res-
onance imaging (MRI)-based body composition analysis
revealed that the majority of the body mass difference be-
tween the AdLKO and control animals on a chow diet is
coming from fat, whereas the lean mass of the two types
of mice is comparable (Fig. 4B). The weights of the inter-
scapular brown adipose depot, the inguinal subcutaneous
white adipose depot, and the epididymal white adipose
depot of the AdLKOmice increased relative to the control
by 120%, 40%, and 15% (Fig. 4C). By gross appearance,
the AdLKO BAT looks larger and paler (Fig. 4D). This phe-
notype cannot be a consequence of CRE recombinase ex-
pression alone in the BAT, as the heterozygous BAT
Zeng et al.
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(lsd1loxP/+;cre+) is indistinguishable from the control (Fig.
4D). Histological analysis of the AdLKO BAT and the in-
guinal WAT revealed a rather massive lipid accumulation
relative to the control, whereas the AdLKO epididymal
WATwas similar to the control (Fig. 4E). The histology re-
sults are consistent with the relative differences in gross
tissue weights of different depots (Fig. 4C). At the
whole-body level, the AdLKO mice have significantly re-
duced oxygen consumption and carbon dioxide produc-
tion rates relative to the controls, with unaltered food
intake and physical activity (Fig. 4F; Supplemental Fig.
S3A,B). We also challenged the mice with a high-fat diet.
Compared with the control mice, the AdLKOmice gained
weight more rapidly (Supplemental Fig. S3C), showed re-
duced energy expenditure rate but unaltered food intake
and movement (Supplemental Fig. S3D–F), and were less
glucose-tolerant (Supplemental Fig. S3G). Because the
BAT is highly active at performing FAO and thermogene-
sis, the most straightforward explanation for these pheno-
types on the chow or high-fat diet is that ablation of LSD1
from the BAT results in a defect in FAO and thermo-
genesis, which in turn leads to lipid accumulation in all
adipose depots and a reduction in whole-body energy ex-
penditure. It is worth noting that mice rendered deficient
for PRDM16 alone in the BAT do not display metabolic
phenotypes of a similar magnitude at this young age
Figure 3. LSD1 and PRDM16 co-occupy loci near white-selective genes and regulate local histone methylation levels. (A) Genomic dis-
tribution of peaks identified in PRDM16 and LSD1 ChIP-seq. (B) Transcription factor motifs enriched in PRDM16 and LSD1 ChIP-seq
peaks. (P) PRDM16 ChIP; (L) LSD1 ChIP. (C ) H3K4me1 and H3K4me2 levels at the retn and agt loci in control and PRDM16-deficient
or LSD1-deficient BAT. (LC) LSD1 floxed BAT; (LK) LSD1-deficient BAT; (PC) PRDM16 floxed BAT; (PK) PRDM16-deficient BAT.
LSD1 represses HSD11B1 to promote BAT activity
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(Harms et al. 2014), suggesting that the phenotype of the
AdLKO mice likely reflects regulatory roles of LSD1 in
the BAT that are independent from Prdm16.
AdLKO brown adipocytes have a blunted response to
norepinephrine
To assess whether the FAO/thermogenesis capacity is
compromised in the AdLKO BAT, we measured the respi-
ration rates of freshly isolated mature brown adipocytes
from the AdLKO and control mice with a Clark-type
oxygen electrode in the absence or presence of norepi-
nephrine. Norepinephrine induces lipolysis in brown adi-
pocytes, which both provides fuels for FAO and directly
activates UCP1. Previous studies have established that
the norepinephrine-induced mature brown adipocyte res-
piration is fully dependent on UCP1, and thus this assay
offers a good estimate of BAT thermogenesis (Anita
et al. 2000). Indeed, norepinephrine strongly stimulated
respiration of the control cells, whereas this effect was
Figure 4. AdLKO mice display an obese phenotype. (A) Body weight curves of male control and AdLKO mice on a chow diet. Mean ±
SEM. n = 15. (∗) P < 0.05; (∗∗) P < 0.01. (B) Body composition of male control and AdLKO mice on a chow diet. Mean ± SEM. n = 15. (∗∗∗)
P < 0.001. (C ) Mass of individual fat depots of male control and AdLKO mice. Mean ± SEM. n = 10. (∗) P < 0.05; (∗∗∗) P < 0.001. (D) Gross
appearance of BAT from control, heterozygous, and homozygous LSD1 knockout mice. (E) Histology of BAT from control and AdLKO
mice. Bar, 200 µm. (F ) Whole-body energy expenditure of control and AdLKO mice. Mean ± SEM. n = 8; P < 0.001, two-way ANOVA.
All mice were 8 wk old unless otherwise specified.
Zeng et al.
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blunted in the AdLKO cells, indicating a reduced thermo-
genic capacity (Fig. 5A). The dampened response to nor-
epinephrine is unlikely to be due to weaker adrenergic
receptor signaling, as the AdLKO cells releasedmore glyc-
erol in response to norepinephrine (Supplemental Fig.
S4A).We also treated cells with oleate, which bypasses ad-
renergic signaling-driven lipolysis and directly stimulates
brown adipocyte respiration in a fully UCP1-dependent
manner (Anita et al. 2000). Again, the AdLKO brown adi-
pocytes displayed a blunted response to oleate relative to
the control (Fig. 5B). These results indicate at the cellular
level that there is a defect in the FAO/thermogenic capac-
ity of the AdLKO BAT, which probably lies downstream
from the adrenergic signaling pathway.
Another possibility that may contribute to the lipid ac-
cumulation phenotype of the AdLKO BAT is increased li-
pogenesis. To measure lipogenesis, we incubated freshly
isolated control or LSD1-deficient brown adipocytes
with 14C-labeled glucose in the presence or absence of
insulin and measured the amount of radioactivity incor-
porated into the triglyceride fraction extracted with or-
ganic solvents. The results showed that the LSD1-
deficient brown adipocytes converted a lower amount of
glucose into triglyceride in both the presence and absence
of insulin relative to the control (Supplemental Fig. S4B),
which suggested that increased lipogenesis cannot be
the reason accounting for the AdLKO BAT phenotype.
AdLKO BAT mitochondria have reduced levels
of FAO/oxidative phosphorylation proteins
and slower respiration rates on fatty acid
substrates
To understand the molecular basis of the FAO/thermo-
genesis defect of the AdLKO BAT, we performed mass
spectrometry-based proteomic analysis of the AdLKO
and the control BAT. We were able to quantitate a total
of 5704 proteins and identified 581 significantly up-regu-
lated and 303 significantly down-regulated proteins in
the AdLKO BAT relative to the control (Fig. 6A). A com-
plete list of the proteins identified and quantitated is in
Supplemental Table S1. We then performed gene set en-
richment analysis (GSEA) on the proteins that are signifi-
cantly different between the AdLKO and the control.
Gene sets including mitochondrial oxidative phosphory-
lation (62), mitochondrial respiratory chain (18), and
FAO (11) are found to be strongly enriched in the down-
regulated but not the up-regulated pool (Fig. 6B). When
we plotted the position of each of the 200 genes in the ox-
idative phosphorylation set, the result clearly shows clus-
tering of genes in the down-regulated region (42) relative
to the up-regulated region (5) (Fig. 6C). This strongly ar-
gues that the enrichment of the oxidative phosphoryla-
tion set proteins in the down-regulated pool is not
simply a consequence of the most abundant BAT proteins
being detected bymass spectrometry but indeed reflects a
phenotype specific to LSD1 ablation.
A closer inspection of the down-regulated proteins re-
vealed multiple enzymes in the β-oxidation pathway and
many components of the electron transport chain (ETC)
(Supplemental Table S3). Down-regulation of such pro-
teins suggests that the decreased respiration rates ob-
served with isolated brown adipocytes from the AdLKO
mice may be attributable to reduced mitochondrial FAO
and ETC capacity. To test this idea, we measured the res-
piration rates of mitochondria isolated from the AdLKO
and the control BAT with a Clark-type oxygen electrode.
With palmitoyl-carnitine/malate as substrates, the
AdLKO BATmitochondria displayed a significantly lower
respiration rate than the control (Fig. 6D). It is notable
Figure 5. LSD1-deficient brown adipo-
cytes have reduced respiration rates. (A)
Oxygen consumption rates of freshly isolat-
ed control and LSD1-deficient brown adipo-
cytes in response to norepinephrine. Mean
± SEM. n = 5. (∗) P < 0.05; (∗∗∗) P < 0.001. A
pair of representative raw traces are shown.
(B) Oxygen consumption curves of freshly
isolated control and LSD1-deficient brown
adipocytes in response to oleate. Mean ±
SEM. n = 5. (∗) P < 0.05; (∗∗) P < 0.01. A pair
of representative raw traces are shown.
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that, although the magnitude of down-regulation of each
individual component in the FAO and ETC pathway is
modest, the overall rate of mitochondrial respiration
when palmitoyl-carnitine is used as the substrate is re-
duced substantially (∼50%), possibly reflecting amultipli-
cative effect of reduced catalytic capacity at different steps
(Spiegelman andHeinrich 2004). Taken together, these re-
sults strongly suggest that the whole-bodymetabolic phe-
notype of decreased energy expenditure rate and increased
body fat accumulation of theAdLKOmice is likely at least
Figure 6. Mitochondria from LSD1-deficient BAT have reduced FAO capacity. (A) Volcano plot of mass spectrometry-based proteomics
of the control and LSD1-deficient BAT. (B) GSEA of proteins that are significantly different between the control and LSD1-deficient BAT.
(C ) Distribution of 200 proteins of the oxidative phosphorylation set in the volcano plot shown in A. (D) Oxygen consumption curves of
mitochondria isolated from control and LSD1-deficient BAT with palmitoyl-cartinine as the substrate. (FCCP) Carbonyl cyanide-4-(tri-
fluoromethoxy)phenylhydrazone. Mean ± SEM. n = 5. (∗∗∗) P < 0.001. A pair of representative raw traces are shown.
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in part due to reductions in the levels of mitochondrial
proteins involved in the FAO and ETC pathway.
Deletion of HSD11B1 results in a substantial rescue
of the AdLKO BAT phenotype
We sought to understand the mechanistic links between
the ablation of LSD1 and the mitochondrial respiration
defect of brown adipocytes. Because LSD1 is best known
as a corepressor, we reasoned that the AdLKO BAT defect
might be a consequence of derepression of certain critical
LSD1 target genes. We therefore examined genes that
are both abundantly expressed and strongly up-regulated
in the AdLKO BAT relative to the control; our atten-
tion turned to the GC-activating enzyme HSD11B1,
observed to be elevated in both the RNA-seq and proteo-
mics data sets (Supplemental Table S1). We confirmed
the up-regulation of HSD11B1 in the AdLKO BAT by
qPCR (Fig. 7A). Importantly, HSD11B1 expression
decreases modestly in the PRDM16-deficient BAT
(Supplemental Fig. S5A), again highlighting that the
LSD1-mediated repression of HSD11B1 reflects an inde-
pendent activity from PRDM16.
HSD11B1 is responsible for generating the biologically
active form of GC hormones (corticosterone in rodents)
from the inert form (11-dehydrocorticosterone [11-DHC]
in rodents) in various tissues, and GC excess is known to
induce obesity in mammals (Seckl and Walker 2001). In-
terestingly, adipose-specific overexpression of HSD11B1
creates a metabolic phenotype similar to what we ob-
served with the AdLKO mice (Masuzaki et al. 2001). We
therefore tested the hypothesis that HSD11B1 is a direct
target of repression by LSD1 and that the derepression of
HSD11B1 followed by loss of LSD1 leads to BAT dysfunc-
tion. We observed increased levels of HSD11B1 mRNA in
primary brown adipocytes differentiated in vitro under
conditions of either pharmacological inhibition or genetic
ablation of LSD1, suggesting that the elevated expression
of HSD11B1 is a cell-autonomous effect of LSD1 inactiva-
tion (Supplemental Fig. S5B,C). LSD1 ChIP-seq revealed
clear binding at the promoter region of hsd11b1, and the
local level of H3K4me2 increases significantly in the
LSD1-deficient BAT relative to the control (Fig. 7B), which
provide evidence of direct repression. To obtain functional
evidence that the up-regulation ofHSD11B1 is responsible
for the AdLKO BAT dysfunction, we crossed the AdLKO
line into a previously reported global hsd11b1 knockout
line to construct a double-knockout line (Semjonous
et al. 2011). The deletion of HSD11B1 was confirmed by
both Western blot (Fig. 7C) and HSD11B1 oxo-reductase
activity assay (reduction of 11-DHC to corticosterone)
conductedwithminced BAT (Fig. 7D).Weobserved no dif-
ference in the serumcorticosterone levels betweenmice of
various genotypes (Supplemental Fig. S5D), suggesting
that the elevated GC activation may be restricted to the
adipose tissue. This same phenomenon was also observed
with the adipose-specific HSD11B1 transgenic mouse
(Masuzaki et al. 2001). On a chow diet, the morphology
and triglyceride content of the hsd11b1 knockout (HKO)
BAT are indistinguishable from the control, whereas the
double-knockout BAT showed significant reduction in
the triglyceride content relative to the AdLKO (Fig. 7E).
This strongly suggests that the increased expression of
HSD11B1 is indeedan important factor contributing to lip-
id accumulation and functional impairment of theAdLKO
BAT. In linewith this,mitochondria isolated fromthedou-
ble-knockout BAT displayed significantly higher respira-
tion rates with palmitoyl-carnitine/malate as substrates
than the AdLKO (Fig. 7F). Finally, at thewhole-body level,
the double-knockoutmicewere found tohavehigher ener-
gy expenditure rates than the AdLKO (Fig. 7G). Taken to-
gether, this evidence strongly supports that the up-
regulation ofHSD11B1 is responsible for a substantial frac-
tion of the BAT dysfunction observed in the AdLKOmice.
Discussion
In this study, we show that the repressive histone deme-
thylase LSD1 physically interacts with and colocalizes
with PRDM16 to genomic loci near WAT-selective genes
that are targets of repression by PRDM16 in brown adipo-
cytes. Loss of either LSD1 or PRDM16 results in up-regu-
lation of local levels of H3K4me1 and H3K4me2 and
increased expression of these WAT-selective genes in
brown adipocytes. This strongly suggests that LSD1-me-
diated demethylation of H3K4 is a critical mechanism
used by PRDM16 to achieve repression of WAT-selective
genes in brown adipocytes. Ablation of LSD1 also causes
impaired mitochondrial FAO/thermogenesis activity, at
least in part due to elevated expression of HSD11B1, a di-
rect target of repression by LSD1. Our studies thus provide
insights into how epigenetic mechanisms regulate meta-
bolic activity of adipocytes.
Previous studies also showed that the BAT and the skel-
etal muscle share a common developmental origin, as
cells from both types of tissue are derived from a popula-
tion of myf5+ progenitors. Moreover, PRDM16 seems to
repress the myogenic programwhile promoting adipogen-
esis during BAT development (Seale et al. 2008). Repres-
sion of the myogenic program is carried out by EHMT1,
a repressive histone H3K9 methyltransferase copurified
with PRDM16 (Ohno et al. 2013). Interestingly, most of
the WAT-selective genes that are up-regulated in both
the PRDM16-deficient and LSD1-deficient BAT do not
change significantly in the EHMT1-deficient BAT, sug-
gesting that EHMT1 selectively targets at the myogenic
but not the WAT-selective genes (Ohno et al. 2013). On
the other hand, we did not observe any up-regulation of
myogenic genes in LSD1-deficient BAT (data not shown).
It is therefore likely that LSD1 is specialized to repress
WAT-selective genes but not myogenic genes together
with PRDM16; thus, LSD1 mediates a distinct arm of
the repressor function of PRDM16 from EHMT1. This
division of labor is further supported by the observation
that EHMT1 andCTBP1 interact with different fragments
of PRDM16 (Ohno et al. 2013). Further study is required to
clarify whether the PRDM16/EHMT1 and PRDM16/
LSD1 represent distinct complexes and whether the re-
pression of WAT-selective or myogenic genes is mediated
by distinct sequence-specific transcription factors.
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Besides WAT-selective genes that are common repres-
sion targets of PRDM16 and LSD1, we also observed co-
occupancy by PRDM16 and LSD1 at loci near some (but
not all) BAT-selective genes that are targets of activation
by PRDM16. Ablation of LSD1 has no effect on the
levels of H3K4me1 and H3K4me2 at those loci. These
Figure 7. Simultaneous deletion of HSD11B1 substantially rescues the metabolic phenotype of the AdLKO mice. (A) mRNA levels of
HSD11B1 in the control and LSD1-deficient BAT. (AdLHKO) Heterozygous LSD1 knockout. Mean ± SEM. n = 5. (∗∗∗) P < 0.001. (B)
H3K4me2 levels near the HSD11B1 promoter region in the control and LSD1-deficient BAT. (C ) Western blot for HSD11B1 in the control,
LSD1 single-knockout, and LSD1/HSD11B1 double-knockout BAT. (D) HSD11B1 activity assay of control, HSD11B1 single-knockout
(HKO), LSD1 single-knockout (LKO), and LSD1/HSD11B1 double-knockout (LHDKO) BAT. Mean ± SEM. n = 5. (∗) P < 0.05; (∗∗) P < 0.01;
(∗∗∗) P < 0.001. (E) Histology and triglyceride contents of the control, HSD11B1 single-knockout (HKO), LSD1 single-knockout (LKO),
and LSD1/HSD11B1 double-knockout (LHDKO) BAT. Bar, 200 µm. (F ) Oxygen consumption rates of mitochondria isolated from LSD1
single-knockout (LKO) and LSD1/HSD11B1 double-knockout (LHDKO) BAT with palmitoyl-cartinine as the substrate. Mean ± SEM. n
= 5. (∗∗∗) P < 0.001. A pair of representative raw traces are shown. (G) Whole-body energy expenditure of LSD1 single-knockout (LKO)
and LSD1/HSD11B1 double-knockout (LHDKO) mice. P < 0.001, two-way ANOVA. All mice were 8 wk old.
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observations suggest that there is amechanism that is pre-
venting LSD1 from demethylating and inducing repres-
sion of those BAT-selective genes even if LSD1 is
brought into close proximity together with PRDM16.
Two reports showed that PRDM16 activates transcription
of BAT-selective genes by recruiting MED1, a component
of the mediator complex, to enhancer regions nearby
(Harms et al. 2015; Iida et al. 2015). It is possible that
the corecruitment of MED1 or additional members of
the mediator complex by PRDM16 alters the enzymatic
activity or substrate accessibility of LSD1 to render it non-
operative at loci near BAT-selective genes. This idea can
be tested by replacing endogenous PRDM16 with a mu-
tant that fails to interact with MED1 but still interacts
with LSD1. This would predict that LSD1may now deme-
thylate and repress BAT-selective genes as well. Mean-
while, we also observed PRDM16 ChIP-seq peaks near
BAT-selective genes that show no or a very low level of
LSD1 binding, suggesting that there may exist PRDM16
complexes devoid of corepressors. These may be consid-
ered to be specialized in transcriptional activation. The
composition of these potentially distinct PRDM16 com-
plexes, especially the nature of sequence-specific tran-
scription factors contained in each complex, deserves
further investigation.
In two previous studies, Duteil et al. (2014) found that
transgenic overexpression of LSD1 promotes expression
of mitochondrial and thermogenic genes in the WAT,
whereas Hino et al. (2012) made the opposite observation.
Neither group used an adipose-specific loss-of-function
model. Although we focused on the BAT in the present
study, we did observe increased expression of some mito-
chondrial and thermogenic genes in the subcutaneous but
not the visceral WAT of the AdLKOmice, suggesting that
LSD1 may be involved in repressing the thermogenic pro-
gram in beige adipocytes. Because beige adipocytes under-
go a rapid “whitening” process upon reacclimation to
warmth after cold exposure, there may exist a beige-spe-
cific mechanism to repress the thermogenic program,
with LSD1 being a part of it. Future study focusing on
the role of LSD1 in beige adipocytes may provide impor-
tant insights into how these cells silence the thermogenic
program.
In addition to LSD1, we also identified several other
known components of the CTBP corepressor complex
bound to PRDM16, and it will be interesting to know
whether they share similar functions with LSD1 in the
BAT. Among them, the role of ZFP516 in BAT function
and development has been studied (Dempersmier et al.
2015). Interestingly, the BAT from ZFP516-null embryos
displays strongly elevated myogenic gene expression but
reduced or insignificant changes in WAT-selective gene
expression, whereas we observed no significant change
inmyogenic gene expression but increasedWAT-selective
gene expression. This is in apparent contradiction to the
fact that ZFP516 and LSD1 appear to be in the same
PRDM16 complex. Such a paradoxmay arise from the dif-
ferent genetic models being used; we used a conditional
knockout, whereas Dempersmier et al. (2015) used a glob-
al knockout. Therefore, this could be explained by the dis-
tinct roles of the ZFP516 and LSD1 at different stages of
BAT development. It will be interesting to develop a con-
ditional knockout model of ZFP516 to see whether that
recapitulates the phenotype of the AdLKO mice.
Another function of ZFP516 reported by Dempersmier
et al. (2015) is activating ucp1 transcription via demethyl-
ating H3K9 at the ucp1 proximal promoter region in the
inguinal WAT. While we were preparing this article, the
same group published another paper suggesting that
LSD1 is responsible for the H3K9 demethylation activity
associated with ZFP516 (Sambeat et al. 2016). They fur-
ther showed that BAT-specific LSD1 knockout mice dis-
played an obese phenotype similar to what we observed
with the AdLKO mice and suggested that the reduced
UCP1 expression might be one of the underlying mecha-
nisms. We did not observe any reduction in UCP1 expres-
sion at both the protein and the mRNA level in the
AdLKO BAT, arguing that decreased UCP1 transcription
cannot account for the AdLKO BAT dysfunction. More-
over, as mentioned above, we found ucp1 and a panel of
other mitochondrial and thermogenic genes to be up-reg-
ulated in the inguinal WAT of the AdLKO mice, suggest-
ing that LSD1 is repressing instead of activating the
thermogenic program in the inguinal WAT. Our observa-
tion that deletion of HSD11B1 results in substantial alle-
viation of the LSD1-deficient BAT dysfunction is
consistent with previous studies indicating that GC ex-
cess impairs BAT thermogenesis and promotes obesity
(Strack et al. 1995; Masuzaki et al. 2001). At this stage,
we cannot completely exclude the possibility that dele-
tion of HSD11B1 in tissues other than the BAT may con-
tribute to the improved BAT function. Constructing an
adipose-specific LSD1/HSD11B1 double-knockout line
will provide a more definitive answer. Meanwhile, it is
clear that the double-knockout BAT still accumulates a
significantly higher amount of lipid than the control, sug-
gesting that additional mechanisms other than HSD11B1
derepression contribute to the BAT defect. Further studies
will be required to understand the intimate balance be-
tween distinct fat cell programs influenced by LSD1.
Materials and methods
Antibodies
PRDM16 antibody for immunoprecipitation, ChIP, and Western
blot was from R&D Systems (AF6295). LSD1 antibody for West-
ern blot was from Abcam (ab17721), and LSD1 antibody for
ChIP was from EMD Millipore (05-939). CTBP1 antibody was
fromAbcam (ab129181). H3K4me1 antibodywas fromDiagenode
(C1540194). H3K4me2 antibody was from EMD Millipore (07-
030). HSD11B1 antibody was from Abcam (ab39364).
Animals
Lsd1flox andhsd11b1 knockoutmicewere obtained from the orig-
inal publishers. The adiponectin-Cre line was maintained in the
Spiegelman laboratory. All strains were on the C57Bl6 back-
ground. All animal experiments were approved by the Dana
Farber Cancer Institute Institutional Animal Care and Use
Committee.
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Adenovirus production and purification
Adenoviral expression constructs were made with the ViraPower
adenoviral expression system (ThermoFisher, K493000). Ampli-
fied adenoviruses were purified with the Fast Trap adenovirus pu-
rification and concentration kit (EMD Millipore, FTAV00003),
and the titer was determined with the Adeno-X rapid titer kit
(Clontech, 632250).
Cell cultures
The stromal vascular fraction containing primary brown preadi-
pocytes was isolated as described previously (Harms et al.
2014). Cells were induced to differentiate after reaching conflu-
encywithmedium containing 10%FBS, 0.5mM isobutylmethyl-
xanthine, 125 µM indomethacin, 5 µM dexamethasone, 80 nM
insulin, and 1 nMT3. For adenoviral infection, cellswere incubat-
ed with the viruses on day 2 after the start of differentiation at
amultiplicity of infection (MOI) of∼1:100 overnight. For pharma-
cological inhibition of LSD1, cells were treated with S2101
(Calbiochem, 489477) from days 2 to 6 after the start of
differentiation.
Protein purification
To purify endogenous PRDM16, PRDM16 antibody was
covalently coupled to protein G Dynabeads (ThermoFisher,
10004D) following the manufacturer’s instructions. Primary
brown preadipocytes were isolated from 40 pups, split to 40 10-
cm plates, and induced to differentiate. On day 4 after differenti-
ation, cells were scraped off the plates, and nuclear extract was
prepared as described previously (Dignam et al. 1983). The nucle-
ar extract was incubated with the antibody beads for 3 h at 4°C
and washed extensively. Bound proteins were eluted with 0.1 M
glycine (pH 2.5) and neutralized with Tris. To purify Flag-tagged
PRDM16, anti-Flag M2 affinity gel (Sigma, A2220) was used.
Bound proteins were eluted with 100 µg/mL 3xFlag peptide
(Sigma, F4799).
Mass spectrometry
A detailed description of the mass spectrometry experimental
procedure is in the Supplemental Material.
ChIP-seq
BAT from 10–15mice (male, 8–10 wk old) were dissected and ho-
mogenized with a douncer. Paraformaldehyde was added to the
homogenate to 1% final concentration. Homogenizationwas per-
formed prior to cross-linking because it is difficult to collect ma-
ture brown adipocytes by centrifugation. The homogenate was
then quenchedwith 125mMglycine, and the nucleiwere collect-
ed by centrifugation. The nuclei were lysed with lysis buffer (1%
SDS, 50 mM Tris-HCl, 10 mM EDTA at pH 8.0) and sonicated to
yield an average size of DNA fragment of 150–200 base pairs (bp).
The lysate was diluted 10-fold with a dilution buffer (0.01% SDS,
1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, 167 mM
NaCl at pH 8.0) and incubated with the desired antibody over-
night. The protein–DNA complex was isolated with protein G
Dynabeads, washed, and eluted off the beads. The eluent was
treated with RNase A and proteinase K before reversing cross-
linking. DNA was then harvested by ethanol precipitation, and
a library was prepared with the NEBNext ChIP-seq library prepa-
ration master mix set for Illumina (New England Biolabs,
E6240S). The library was sequenced on an Illumina Nextseq
500 sequencer, and raw reads were mapped with the mapping
tool in the CLC Genomics Workbench software. Peaks were
called with the model-based analysis for ChIP-seq (MACS) meth-
od, and the P-value threshold was set at 0.05. Subsequent analy-
ses, including genomic distribution, peak set overlap, and
transcription factormotif enrichment, were performedwith tools
on the DFCI Galaxy Cistrome Web site.
RNA-seq
Total RNAwas isolated from BATwith the Trizol reagent (Ther-
moFisher, 15596026). mRNA was purified with the Magenic
mRNA isolation kit (New England Biolabs, S1550S), and a library
was prepared with the NEBNext Ultra RNA library preparation
kit for Illumina (New England Biolabs, E7530S). The library was
sequenced on an Illumina Nextseq 500 sequencer. Raw reads
were aligned using a STAR aligner (version STAR_2.4.2a), and
raw gene counts were quantified using the quantMode Gene-
Counts flag. Differential expression testing was performed using
Limma and DESeq2.
Metabolic phenotyping
All experiments were done with male mice. Energy expenditure
was analyzed using a Comprehensive Lab Animal Monitoring
System (Columbus Instruments). Fat and lean mass were mea-
sured by MRI.
Respiration assay
To measure mature brown adipocyte respiration, BAT was dis-
sected,minced, and digestedwithKrebs Ringer bicarbonate-mod-
ified buffer (KRBMB; 120 mM NaCl, 5 mM KCl, 1 mM MgCl2,
1mMCaCl2, 0.4mMK2HPO4, 10mMglucose, 15mMNaHCO3,
20 mMHEPES at pH 7.4, 4% fatty acid free BSA), 2 mg/mL colla-
genase B (Worthington, CLSAFB), and 1 mg/mL soybean trypsin
inhibitor (Worthington, LS003570) for 30 min at 37°C. Cells
were washed three times with KRBMB and allowed to recover
for at least 30 min at room temperature. An oxygen electrode
(Strathkelvin Instrument, SI130) installed in a respiration cham-
ber (StrathKelvin Instrument, MT200A) was used to measure ox-
ygen consumption rate. Cells were counted by lysis followed by
Trypan blue staining of the nuclei. For each run, 150,000 cells
were suspended in 1 mL of KRBMB and added to the respiration
chamber. Norepinephrine (1 µM) or 3 mM sodium oleate was in-
jected into the chamber to stimulate respiration. To measure mi-
tochondrial respiration, crude mitochondria were isolated from
the BAT following a procedure described previously (Nedergaard
and Cannon 1979). For each run, an amount of 200 µg of protein
was used. Palmitoyl-carnitine (40 µM), 5 mM malate, 1 mM
GDP, and 1 µM FCCP were sequentially injected into the
chamber.
HSD11B1 activity assay
Freshly dissected BAT (∼10 mg) was minced and suspended in
2 mL of serum-free medium supplemented with or without
100 nM 11-DHC and incubated for 2 h at 37°C. The supernatant
was collected, and the corticosterone level was measured by
ELISA (ab108821). Samples without 11-DHCwere used for back-
ground subtraction.
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Statistical analysis
The Student’s t-test was used for single comparisons. Two-way
ANOVA with repeated measures was used for body weight and
energy expenditure comparisons.
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